MMP2 and glioblastoma: Recombinant human SHH N-terminal peptide (rhSHH) enhances HH signalling, leading to increased mRNA levels of matrix metalloproteinase-2 (MMP2) and MMP9, which facilitate the adhesion and invasion of GBM cells [31].